ArticleScientific reports2019

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma.

Adèle Mangelinck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.